The peer table above lists ETFs with the same asset class and broad strategy as State Street SPDR S&P Biotech ETF (XBI). Compare expense ratio, AUM, and dividend yield to evaluate alternatives.
How does XBI compare to other ETFs in its category?
Each peer row shows expense ratio and AUM alongside XBI so you can spot meaningful gaps — a 0.40% expense ratio vs a 0.06% peer is a real cost difference compounded over the long term. Click any peer to open its full analysis.
What is the expense ratio of XBI?
State Street SPDR S&P Biotech ETF (XBI) charges an expense ratio of 0.35%. This is the annual fee deducted from fund assets to cover management and operations.
